Literature DB >> 7512656

Surgical treatment of invasive squamous cell carcinoma of the penis: retrospective analysis of 350 cases.

A A Ornellas1, A L Seixas, A Marota, A Wisnescky, F Campos, J R de Moraes.   

Abstract

Between 1960 and 1987, 414 patients with invasive squamous cell carcinoma of the penis were referred to the Brazilian National Cancer Institute. Inguinal metastases were demonstrated by lymphadenectomy in 39% of the 23 patients with stage N0, 49% of 92 with stages N1 and N2, and 100% of 18 with stage N3 disease. We analyzed the followup of 350 patients who underwent surgical treatment. In 224 patients (64%) amputation or some form of penile surgery was done initially, while 102 (29%) underwent amputation and lymphadenectomy, and 24 (7%) underwent palliative surgery for advanced squamous cell carcinoma. The statistics revealed a better 5-year survival rate for the patients who underwent lymphadenectomy concomitantly with penile surgery compared to those who underwent delayed lymphadenectomy (p < 0.001). Patients in whom systematic lymphadenectomy was negative had a better prognosis than those with positive systematic lymphadenectomy results (p < 0.001). The latter patients had a better prognosis compared with those in whom delayed lymphadenectomy was positive (p = 0.0103). Patients with well and moderately differentiated carcinoma had a higher survival rate at 5 years than did those with poorly differentiated carcinoma (p < 0.001 and p = 0.003, respectively). All deaths from metastatic disease occurred within 24 months among the patients who underwent systematic lymphadenectomy and within 5 years after simple penile surgery. In the short term, surgical debulking combined with reconstruction techniques allowed for improved quality of life in patients with advanced local-regional disease.

Entities:  

Mesh:

Year:  1994        PMID: 7512656     DOI: 10.1016/s0022-5347(17)35222-9

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  46 in total

1.  A case of local advanced penile cancer treated with multimodality therapy.

Authors:  Manabu Kato; Norihito Soga; Kiminobu Arima; Yoshiki Sugimura
Journal:  Int J Clin Oncol       Date:  2010-04-16       Impact factor: 3.402

Review 2.  Surgical management of metastatic inguinal lymphadenopathy.

Authors:  Marc C Swan; Dominic Furniss; Oliver C S Cassell
Journal:  BMJ       Date:  2004-11-27

Review 3.  Contemporary management of patients with penile cancer and lymph node metastasis.

Authors:  Andrew Leone; Gregory J Diorio; Curtis Pettaway; Viraj Master; Philippe E Spiess
Journal:  Nat Rev Urol       Date:  2017-04-11       Impact factor: 14.432

Review 4.  [Systemic therapy of penile cancer].

Authors:  E Preis; P Albers; G Jakse
Journal:  Urologe A       Date:  2006-05       Impact factor: 0.639

Review 5.  [Options in palliative therapy for penile cancer].

Authors:  E Preis; G Jakse
Journal:  Urologe A       Date:  2007-01       Impact factor: 0.639

6.  Penile cancer: a case for guidelines.

Authors:  N P Munro; P J Thomas; G P Deutsch; N J Hodson
Journal:  Ann R Coll Surg Engl       Date:  2001-05       Impact factor: 1.891

Review 7.  [The significance of lymphadenectomy in the management of penile cancer].

Authors:  M Angerer-Shpilenya; G Jakse
Journal:  Urologe A       Date:  2009-01       Impact factor: 0.639

8.  Video Endoscopic Inguinal Lymphadenectomy (VEIL): Minimally Invasive Radical Inguinal Lymphadenectomy Technique.

Authors:  Rawal Sudhir; Raghunath S Krishnappa; Samir Khanna; R Sekon; Rakesh Koul
Journal:  Indian J Surg Oncol       Date:  2012-07-04

9.  What next? Managing lymph nodes in men with penile cancer.

Authors:  Michael Leveridge; D Robert Siemens; Christopher Morash
Journal:  Can Urol Assoc J       Date:  2008-10       Impact factor: 1.862

Review 10.  Current trends in the management of carcinoma penis--a review.

Authors:  Iqbal Singh; A Khaitan
Journal:  Int Urol Nephrol       Date:  2003       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.